BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 15549447)

  • 1. Evaluation of venous thromboembolism and coagulation-fibrinolysis markers in Japanese patients with inflammatory bowel disease.
    Sonoda K; Ikeda S; Mizuta Y; Miyahara Y; Kohno S
    J Gastroenterol; 2004 Oct; 39(10):948-54. PubMed ID: 15549447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study.
    Bernstein CN; Blanchard JF; Houston DS; Wajda A
    Thromb Haemost; 2001 Mar; 85(3):430-4. PubMed ID: 11307809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study.
    Kappelman MD; Horvath-Puho E; Sandler RS; Rubin DT; Ullman TA; Pedersen L; Baron JA; Sørensen HT
    Gut; 2011 Jul; 60(7):937-43. PubMed ID: 21339206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy insight: Vascular complications in patients with inflammatory bowel disease.
    Koutroubakis IE
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):266-72. PubMed ID: 16265230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications?
    Oldenburg B; Fijnheer R; van der Griend R; vanBerge-Henegouwen GP; Koningsberger JC
    Am J Gastroenterol; 2000 Oct; 95(10):2825-30. PubMed ID: 11051355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombopoietin serum levels in patients with inflammatory bowel disease with and without previous thromboembolic events.
    Papa A; Danese S; Piccirillo N; Toriani-Terenzi C; Bartolozzi F; Piscaglia AC; Grillo A; Leone G; Gentiloni-Silveri N; Gasbarrini G; Gasbarrini A
    Hepatogastroenterology; 2003; 50(49):132-5. PubMed ID: 12630008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission.
    Herrlinger KR; Noftz MK; Dalhoff K; Ludwig D; Stange EF; Fellermann K
    Am J Gastroenterol; 2002 Feb; 97(2):377-81. PubMed ID: 11866276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exclusion of venous thromboembolism: evaluation of D-Dimer PLUS for the quantitative determination of D-dimer.
    Vermeer HJ; Ypma P; van Strijen MJ; Muradin AA; Hudig F; Jansen RW; Wijermans PW; Gerrits WB
    Thromb Res; 2005; 115(5):381-6. PubMed ID: 15733971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease.
    Koutroubakis IE; Sfiridaki A; Tsiolakidou G; Coucoutsi C; Theodoropoulou A; Kouroumalis EA
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):912-6. PubMed ID: 18794606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of altered coagulation and fibrinolysis as measures of disease activity in active inflammatory bowel disease: a gender-stratified, cohort analysis.
    Shen J; Ran ZH; Zhang Y; Cai Q; Yin HM; Zhou XT; Xiao SD
    Thromb Res; 2009 Feb; 123(4):604-11. PubMed ID: 18499234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk of thromboembolic phenomena in patients with inflammatory bowel disease].
    Suárez Ferrer C; Vera Mendoza MI; Amo San Román L; González Lama Y; Calvo Moya M; García Casas M; Abreu García L
    Gastroenterol Hepatol; 2012 Nov; 35(9):634-9. PubMed ID: 23036695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of patients hospitalized with venous thromboembolism: comparison between cancer and non-cancer patients.
    Kolomansky A; Hoffman R; Sarig G; Brenner B; Haim N
    Isr Med Assoc J; 2006 Dec; 8(12):848-52. PubMed ID: 17214102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy.
    Secin FP; Jiborn T; Bjartell AS; Fournier G; Salomon L; Abbou CC; Haber GP; Gill IS; Crocitto LE; Nelson RA; Cansino Alcaide JR; Martínez-Piñeiro L; Cohen MS; Tuerk I; Schulman C; Gianduzzo T; Eden C; Baumgartner R; Smith JA; Entezari K; van Velthoven R; Janetschek G; Serio AM; Vickers AJ; Touijer K; Guillonneau B
    Eur Urol; 2008 Jan; 53(1):134-45. PubMed ID: 17597288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's disease: relations to disease activity and corticosteroid treatment.
    Eivindson M; Grønbaek H; Flyvbjerg A; Frystyk J; Zimmermann-Nielsen E; Dahlerup JF
    Growth Horm IGF Res; 2007 Feb; 17(1):33-40. PubMed ID: 17126585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated thrombopoietin serum levels in patients with inflammatory bowel disease.
    Kapsoritakis AN; Potamianos SP; Sfiridaki AI; Koukourakis MI; Koutroubakis IE; Roussomoustakaki MI; Manousos ON; Kouroumalis EA
    Am J Gastroenterol; 2000 Dec; 95(12):3478-81. PubMed ID: 11151880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of prothrombin activation fragments in young patients with inflammatory bowel disease.
    Smith CJ; Haire WD; Kaufman SS; Mack DR
    Am J Gastroenterol; 1996 Jun; 91(6):1221-5. PubMed ID: 8651175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating D dimer in inflammatory bowel disease.
    Biancone L; Scopinaro F; Maletta M; Monteleone G; Luzza F; Banci M; Mercantini P; Renda T; Pallone F
    Ital J Gastroenterol; 1994 Apr; 26(3):116-20. PubMed ID: 8061337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease.
    Novacek G; Miehsler W; Kapiotis S; Katzenschlager R; Speiser W; Vogelsang H
    Am J Gastroenterol; 1999 Mar; 94(3):685-90. PubMed ID: 10086652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of coagulation and angiogenesis in cancer-associated venous thromboembolism.
    Goldenberg N; Kahn SR; Solymoss S
    J Clin Oncol; 2003 Nov; 21(22):4194-9. PubMed ID: 14615447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.